Low-grade squamous intraepithelial lesion of the cervix
Conditions
Interventions
Retrospective analysis(focused ultrasound treatment group):Focused ultrasound therapy
Retrospective analysis (Leep treatment group):Leep treatment group
Retrospective analysis(Interferon treatment group):Drug therapy
Prospective cohort study(focused ultrasound treatment group):Focused ultrasound therapy
Prospective cohort study (Leep treatment group):Leep treatment group
Prospective cohort study(Interferon treatment group):Drug therapy
Sponsors
Chongqing University Affiliated Three Gorges Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1) not receiving other drugs, physical therapy, or major surgery within 3 months; 2) diagnosis of high-risk HPV infection by HPV-DNA testing; 3) LSIL was diagnosed if the colposcopy results were satisfactory (satisfactory: the cervical squamo-column junction was completely visible); 4) understand the condition and can express normally; 5) those who agreed to enter the cohort study and signed the consent form; 6) non-pregnant or lactating women; 7) no acute genital tract inflammation.
Exclusion criteria
Exclusion criteria: 1) patients who refuse to participate in the study; 2) co-infection with other sexually transmitted diseases; 3) other serious tissue, organ or system lesions; 4) unsatisfactory colposcopy or lesion located in the cervical canal; 5) uncontrolled diabetes, hyperthyroidism or hypothyroidism; 6) severe blood diseases, coagulation disorders, cardiovascular and cerebrovascular diseases, immune system diseases, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whether HPV turns negative;Cervical cytological examination; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cluster of differentiation 4;Cluster of differentiation 8;Colposcopy; | — |
Countries
China
Contacts
Public ContactMingju Huang
Chongqing University Affiliated Three Gorges Hospital
Outcome results
None listed